The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Offering choice of CRC screening increases completion rates
May 21, 2024
The rate of colorectal cancer screening improved within six months for those offered fecal immunochemical testing only or a choice of coloscopy or FIT.
AI chatbots can generate quality, empathetic, readable responses
May 17, 2024
Chatbots can generate quality responses to cancer patient questions, comparable to physician responses.
Few cancer survivors fully adherent to ACS nutrition and physical activity guidelines
Apr 23, 2024
Factors associated with greater adherence include female sex, older age, Black race and higher educational level.
Up to 30 percent of CVD mortality attributable to excess salt intake
Mar 29, 2024
The population-attributable risk estimates suggest that sodium above the recommended intake is linked to 10 to 30% of CVD mortality.
Additional benefit seen for colonoscopy versus sigmoidoscopy
Mar 05, 2024
In recent study, fewer colorectal cancer cases and deaths per 100,000 person-years were observed.
Fecal occult blood testing tied to reduction in colorectal cancer mortality
Mar 04, 2024
The findings show a 14% decreased colorectal cancer mortality over 14 years.
FDA: Food packaging containing PFAS no longer sold in the United States
Feb 28, 2024
“Forever chemicals” are tied to a host of health issues and are slow to degrade in the environment.
Reduced cancer risk seen after 10 years since quitting smoking
Feb 08, 2024
After 15 or more years since quitting, the cancer risk reached 50% of that associated with continued smoking.
FDA approves AI device that helps spot skin cancer
Jan 18, 2024
Along with helping to spot melanoma, the most deadly form of skin cancer, the device can also assess moles for basal cell carcinoma and squamous cell carcinoma.